Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in U.S.

Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in U.S.

Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany have announced that human clinical trials for an experimental COVID-19 vaccine they have co-developed, known as BNT162, have begun in the United States.1 As part of a global clinical development program, the first human subjects in the U.S. Phase I and Phase clinical II […]